Michael Badman

Michael Badman

Company: Novartis

Job title: Translational Medicine Expert


NASH Monotherapy: A Tour of the FXR Agonist Menagerie 9:00 am

Read more

day: Day One

NASH Monotherapy: A tour of the FXR Agonist Menagerie 5:00 pm

• Reviewing the development of FXR agonists – from BAs to targeted small molecules • Discussing PD and efficacy measures of FXR in NASH • Understanding safety and tolerability of FXR agonists for NASHRead more

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.